Genetic Variability in VEGFA Gene Influences the Effectiveness of Tennis Elbow Therapy with PRP: A Two-Year Prospective Cohort Study

Vascular endothelial growth factor (VEGF) is implicated in both the etiology of tendinopathy and its healing process. Polymorphic variants of the gene exhibit varied expression, which can influence the phenotype and treatment effectiveness. The aim of the present study was to analyze the influence o...

Full description

Saved in:
Bibliographic Details
Published in:International journal of molecular sciences 2023-12, Vol.24 (24), p.17292
Main Authors: Niemiec, Paweł, Jarosz, Alicja, Balcerzyk-Matić, Anna, Iwanicka, Joanna, Nowak, Tomasz, Iwanicki, Tomasz, Gierek, Marcin, Kalita, Marcin, Garczorz, Wojciech, Francuz, Tomasz, Górczyńska-Kosiorz, Sylwia, Kania, Wojciech, Szyluk, Karol
Format: Article
Language:English
Subjects:
Angiogenesis
Blood platelets
Collagen
Elbow
Extracellular matrix
Genes
genetic polymorphism
Genotype & phenotype
Haplotypes
Influence
Patients
Physiology
platelet-rich plasma
Polymorphism
tendinopathy
Tendons
tennis elbow
Vascular endothelial growth factor
VEGFA
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Vascular endothelial growth factor (VEGF) is implicated in both the etiology of tendinopathy and its healing process. Polymorphic variants of the gene exhibit varied expression, which can influence the phenotype and treatment effectiveness. The aim of the present study was to analyze the influence of gene variants on the effectiveness of tennis elbow therapy using platelet-rich plasma (PRP), measured through common patient-reported outcome measures (PROMs). A cohort of 107 patients (132 elbows) with tennis elbow was prospectively analyzed, with a two-year follow-up (at weeks 2, 4, 8, 12, 24, 52, and 104 after PRP injection). PROMs values were compared between variants of five gene polymorphisms (rs699947 A>C, rs2010963 C>G, rs1413711 C>T, rs3024998 C>T and rs3025021 C>T) at each follow-up point. Patients with genotypes GG (rs2010963) and CC (rs3024998) had better response to PRP therapy (significantly fewer symptoms and limitations in the upper limb compared to carriers of alleles C and T, respectively). Polymorphisms influenced also selected hematological parameters. gene polymorphisms (rs2010963 and rs3024998) appear to be significant treatment modifiers for tendinopathy, and their genotyping may serve as an effective tool for personalized patient selection for PRP therapy.
ISSN:1422-0067
1661-6596
1422-0067
DOI:10.3390/ijms242417292